» Articles » PMID: 33400734

Exploiting the Metabolic Dependencies of the Broad Amino Acid Transporter SLC6A14

Overview
Journal Oncotarget
Specialty Oncology
Date 2021 Jan 5
PMID 33400734
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Tumor cells typically enhance their metabolic capacity to sustain their higher rate of growth and proliferation. One way to elevate the nutrient intake into cancer cells is to increase the expression of genes encoding amino acid transporters, which may represent targetable vulnerabilities. Here, we study the regulation and function of the broad amino acid transporter SLC6A14 in combination with metabolic stress, providing insights into an uncharacterized aspect of the transporter activity. We analyze the pattern of transcriptional changes in a panel of breast cancer cell lines upon metabolic stress and found that SLC6A14 expression levels are increased in the absence of methionine. Methionine deprivation, which can be achieved via modulation of dietary methionine intake in tumor cells, in turn leads to a heightened activation of the AMP-activated kinase (AMPK) in SLC6A14-deficient cells. While SLC6A14 genetic deficiency does not have a major impact on cell proliferation, combined depletion of AMPK and SLC6A14 leads to an increase in apoptosis upon methionine starvation, suggesting that combined targeting of SLC6A14 and AMPK can be exploited as a therapeutic approach to starve tumor cells.

Citing Articles

Phenotypic profiling of solute carriers characterizes serine transport in cancer.

Papalazarou V, Newman A, Huerta-Uribe A, Legrave N, Falcone M, Zhang T Nat Metab. 2023; 5(12):2148-2168.

PMID: 38066114 PMC: 10730406. DOI: 10.1038/s42255-023-00936-2.


Targeting glutamine metabolism as a therapeutic strategy for cancer.

Jin J, Byun J, Choi Y, Park K Exp Mol Med. 2023; 55(4):706-715.

PMID: 37009798 PMC: 10167356. DOI: 10.1038/s12276-023-00971-9.


Airway secretory cell fate conversion via YAP-mTORC1-dependent essential amino acid metabolism.

Jeon H, Choi J, Kraaier L, Kim Y, Eisenbarth D, Yi K EMBO J. 2022; 41(8):e109365.

PMID: 35285539 PMC: 9016350. DOI: 10.15252/embj.2021109365.

References
1.
Cormerais Y, Massard P, Vucetic M, Giuliano S, Tambutte E, Durivault J . The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5). J Biol Chem. 2018; 293(8):2877-2887. PMC: 5827425. DOI: 10.1074/jbc.RA117.001342. View

2.
Broer S, Broer A . Amino acid homeostasis and signalling in mammalian cells and organisms. Biochem J. 2017; 474(12):1935-1963. PMC: 5444488. DOI: 10.1042/BCJ20160822. View

3.
Sloan J, Mager S . Cloning and functional expression of a human Na(+) and Cl(-)-dependent neutral and cationic amino acid transporter B(0+). J Biol Chem. 1999; 274(34):23740-5. DOI: 10.1074/jbc.274.34.23740. View

4.
Ansari R, Craze M, Miligy I, Diez-Rodriguez M, Nolan C, Ellis I . The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumours. Breast Cancer Res. 2018; 20(1):21. PMC: 5863851. DOI: 10.1186/s13058-018-0946-6. View

5.
Hafliger P, Charles R . The L-Type Amino Acid Transporter LAT1-An Emerging Target in Cancer. Int J Mol Sci. 2019; 20(10). PMC: 6566973. DOI: 10.3390/ijms20102428. View